Neoadjuvant and Adjuvant Therapies for High-Risk Prostate Cancer.
2/5 보강
OpenAlex 토픽 ·
Prostate Cancer Diagnosis and Treatment
Prostate Cancer Treatment and Research
Urinary Bladder and Prostate Research
High-risk localized prostate cancer (HR-PCa) presents a substantial risk of recurrence and progression despite definitive local treatment.
APA
Suhas Penukonda, Elias Hyams, et al. (2026). Neoadjuvant and Adjuvant Therapies for High-Risk Prostate Cancer.. The Urologic clinics of North America, 53(2), 233-242. https://doi.org/10.1016/j.ucl.2026.02.006
MLA
Suhas Penukonda, et al.. "Neoadjuvant and Adjuvant Therapies for High-Risk Prostate Cancer.." The Urologic clinics of North America, vol. 53, no. 2, 2026, pp. 233-242.
PMID
41986019 ↗
Abstract 한글 요약
High-risk localized prostate cancer (HR-PCa) presents a substantial risk of recurrence and progression despite definitive local treatment. This article evaluates the evolving role of neoadjuvant and adjuvant therapies, including androgen deprivation therapy, second-generation androgen receptor pathway inhibitors, and chemotherapy. While neoadjuvant strategies improve pathologic responses, survival benefits remain unproven. Adjuvant therapy is increasingly individualized, with early salvage radiotherapy favored over routine adjuvant radiotherapy based on recent trial data. Ongoing studies, molecular profiling, and advanced imaging aim to refine patient selection and personalize treatment, balancing oncologic control with quality of life in the management of HR-PCa.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.